• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding.趋化因子受体CCR8胞外环2中保守二硫键和芳香族残基在趋化因子及小分子结合中的作用
J Biol Chem. 2016 Jul 29;291(31):16208-20. doi: 10.1074/jbc.M115.706747. Epub 2016 May 19.
2
Reversed binding of a small molecule ligand in homologous chemokine receptors - differential role of extracellular loop 2.小分子配体在同源趋化因子受体中的反向结合 - 细胞外环 2 的差异作用。
Br J Pharmacol. 2012 May;166(1):258-75. doi: 10.1111/j.1476-5381.2011.01771.x.
3
Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.分子抑制趋化因子受体 CCR8 的要求——探针依赖的变构相互作用。
Br J Pharmacol. 2012 Nov;167(6):1206-17. doi: 10.1111/j.1476-5381.2012.02076.x.
4
Extracellular disulfide bridges serve different purposes in two homologous chemokine receptors, CCR1 and CCR5.细胞外二硫键在两个同源趋化因子受体 CCR1 和 CCR5 中具有不同的作用。
Mol Pharmacol. 2013 Sep;84(3):335-45. doi: 10.1124/mol.113.086702. Epub 2013 Jun 13.
5
Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.CCR8激动剂和拮抗剂的结构/功能关系。CCL1的氨基末端延伸一个氨基酸会产生一个部分激动剂。
J Biol Chem. 2006 Dec 1;281(48):36652-61. doi: 10.1074/jbc.M605584200. Epub 2006 Oct 5.
6
Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8.人 CC 趋化因子受体 8 的抗体抑制和趋化因子激活的结构基础。
Nat Commun. 2023 Dec 1;14(1):7940. doi: 10.1038/s41467-023-43601-8.
7
Biological characterization of ligands targeting the human CC chemokine receptor 8 (CCR8) reveals the biased signaling properties of small molecule agonists.靶向人趋化因子受体 8(CCR8)的配体的生物学特性揭示了小分子激动剂的偏向信号转导特性。
Biochem Pharmacol. 2021 Jun;188:114565. doi: 10.1016/j.bcp.2021.114565. Epub 2021 Apr 17.
8
Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8.一种强效非肽激动剂与趋化因子受体CCR8的分子相互作用。
Mol Pharmacol. 2007 Aug;72(2):327-40. doi: 10.1124/mol.106.035543.
9
The chemokine receptor CCR8 mediates rescue from dexamethasone-induced apoptosis via an ERK-dependent pathway.趋化因子受体CCR8通过一条依赖细胞外信号调节激酶(ERK)的途径介导从地塞米松诱导的细胞凋亡中挽救出来。
J Leukoc Biol. 2003 Jan;73(1):201-7. doi: 10.1189/jlb.0302105.
10
CC and CX3C chemokines differentially interact with the N terminus of the human cytomegalovirus-encoded US28 receptor.C-C和C-X3-C趋化因子与人类巨细胞病毒编码的US28受体的N端存在不同的相互作用。
J Biol Chem. 2005 Feb 4;280(5):3275-85. doi: 10.1074/jbc.M407536200. Epub 2004 Nov 16.

引用本文的文献

1
Genomes of two invasive species (hemlock woolly adelgid and pineapple gall adelgid) enable characterization of nicotinic acetylcholine receptors.两种入侵物种(铁杉球蚜和菠萝瘿球蚜)的基因组有助于对烟碱型乙酰胆碱受体进行表征。
bioRxiv. 2024 Nov 26:2024.11.21.624573. doi: 10.1101/2024.11.21.624573.
2
Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8.人 CC 趋化因子受体 8 的抗体抑制和趋化因子激活的结构基础。
Nat Commun. 2023 Dec 1;14(1):7940. doi: 10.1038/s41467-023-43601-8.
3
Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue.结构与功能分析 Ccr1l1,一种仅在啮齿动物中表达的嗜酸性粒细胞选择性趋化因子受体同源物。
J Biol Chem. 2021 Jan-Jun;296:100373. doi: 10.1016/j.jbc.2021.100373. Epub 2021 Feb 3.
4
G Protein-Coupled Receptors in the Sweet Spot: Glycosylation and other Post-translational Modifications.处于关键位置的G蛋白偶联受体:糖基化及其他翻译后修饰
ACS Pharmacol Transl Sci. 2020 Mar 17;3(2):237-245. doi: 10.1021/acsptsci.0c00016. eCollection 2020 Apr 10.
5
Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.CCL21 和 CCL19 的偏向信号传递不依赖于 N 端差异,而是明显依赖于 CCR7 的趋化因子核心结构域和细胞外环 2。
Front Immunol. 2019 Sep 13;10:2156. doi: 10.3389/fimmu.2019.02156. eCollection 2019.
6
Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation.EB 病毒编码的 BILF1 受体在信号传导和主要组织相容性复合物 I 下调中的细胞外结构域的独特作用。
mBio. 2019 Jan 15;10(1):e01707-18. doi: 10.1128/mBio.01707-18.

本文引用的文献

1
Two disparate ligand-binding sites in the human P2Y1 receptor.人类P2Y1受体中的两个不同配体结合位点。
Nature. 2015 Apr 16;520(7547):317-21. doi: 10.1038/nature14287. Epub 2015 Mar 30.
2
Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor.结构生物学。趋化因子识别与病毒G蛋白偶联受体激活的结构基础。
Science. 2015 Mar 6;347(6226):1113-7. doi: 10.1126/science.aaa5026.
3
In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.CCR8抑制剂结合模式的计算机模拟表征:同源建模、对接及基于膜的分子动力学模拟研究
J Biomol Struct Dyn. 2015;33(11):2491-510. doi: 10.1080/07391102.2014.1002006. Epub 2015 Jan 23.
4
Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine.结构生物学。趋化因子受体CXCR4与一种病毒趋化因子复合物的晶体结构。
Science. 2015 Mar 6;347(6226):1117-22. doi: 10.1126/science.1261064. Epub 2015 Jan 22.
5
Interaction of chemokines with their receptors--from initial chemokine binding to receptor activating steps.趋化因子与其受体的相互作用——从趋化因子的初始结合到受体激活步骤。
Curr Med Chem. 2014;21(31):3594-614. doi: 10.2174/0929867321666140716093155.
6
Structure of the human P2Y12 receptor in complex with an antithrombotic drug.人源 P2Y12 受体与抗血栓药物复合物的结构。
Nature. 2014 May 1;509(7498):115-8. doi: 10.1038/nature13083. Epub 2014 Mar 23.
7
Structure-activity relationships and identification of optmized CC-chemokine receptor CCR1, 5, and 8 metal-ion chelators.结构-活性关系和优化的 CC-趋化因子受体 CCR1、5 和 8 金属离子螯合剂的鉴定。
J Chem Inf Model. 2013 Nov 25;53(11):2863-73. doi: 10.1021/ci4003848. Epub 2013 Oct 22.
8
Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.CCR5 趋化因子受体-人类免疫缺陷病毒进入抑制剂马拉维若复合物的结构。
Science. 2013 Sep 20;341(6152):1387-90. doi: 10.1126/science.1241475. Epub 2013 Sep 12.
9
Identification of human CCR8 as a CCL18 receptor.鉴定人 CCR8 为 CCL18 受体。
J Exp Med. 2013 Sep 23;210(10):1889-98. doi: 10.1084/jem.20130240. Epub 2013 Sep 2.
10
Extracellular disulfide bridges serve different purposes in two homologous chemokine receptors, CCR1 and CCR5.细胞外二硫键在两个同源趋化因子受体 CCR1 和 CCR5 中具有不同的作用。
Mol Pharmacol. 2013 Sep;84(3):335-45. doi: 10.1124/mol.113.086702. Epub 2013 Jun 13.

趋化因子受体CCR8胞外环2中保守二硫键和芳香族残基在趋化因子及小分子结合中的作用

Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding.

作者信息

Barington Line, Rummel Pia C, Lückmann Michael, Pihl Heidi, Larsen Olav, Daugvilaite Viktorija, Johnsen Anders H, Frimurer Thomas M, Karlshøj Stefanie, Rosenkilde Mette M

机构信息

From the Department of Neuroscience and Pharmacology.

From the Department of Neuroscience and Pharmacology, the Novo Nordisk Foundation Center for Basic Metabolic Research, and.

出版信息

J Biol Chem. 2016 Jul 29;291(31):16208-20. doi: 10.1074/jbc.M115.706747. Epub 2016 May 19.

DOI:10.1074/jbc.M115.706747
PMID:27226537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4965569/
Abstract

Chemokine receptors play important roles in the immune system and are linked to several human diseases. The initial contact of chemokines with their receptors depends on highly specified extracellular receptor features. Here we investigate the importance of conserved extracellular disulfide bridges and aromatic residues in extracellular loop 2 (ECL-2) for ligand binding and activation in the chemokine receptor CCR8. We used inositol 1,4,5-trisphosphate accumulation and radioligand binding experiments to determine the impact of receptor mutagenesis on both chemokine and small molecule agonist and antagonist binding and action in CCR8. We find that the seven-transmembrane (TM) receptor conserved disulfide bridge (7TM bridge) linking transmembrane helix III (TMIII) and ECL-2 is crucial for chemokine and small molecule action, whereas the chemokine receptor conserved disulfide bridge between the N terminus and TMVII is needed only for chemokines. Furthermore, we find that two distinct aromatic residues in ECL-2, Tyr(184) (Cys + 1) and Tyr(187) (Cys + 4), are crucial for binding of the CC chemokines CCL1 (agonist) and MC148 (antagonist), respectively, but not for small molecule binding. Finally, using in silico modeling, we predict an aromatic cluster of interaction partners for Tyr(187) in TMIV (Phe(171)) and TMV (Trp(194)). We show in vitro that these residues are crucial for the binding and action of MC148, thus supporting their participation in an aromatic cluster with Tyr(187) This aromatic cluster appears to be present in a large number of CC chemokine receptors and thereby could play a more general role to be exploited in future drug development targeting these receptors.

摘要

趋化因子受体在免疫系统中发挥着重要作用,并且与多种人类疾病相关。趋化因子与其受体的初始接触取决于高度特定的细胞外受体特征。在此,我们研究了趋化因子受体CCR8中细胞外环2(ECL-2)中保守的细胞外二硫键和芳香族残基对于配体结合和激活的重要性。我们使用肌醇1,4,5-三磷酸积累和放射性配体结合实验来确定受体诱变对CCR8中趋化因子以及小分子激动剂和拮抗剂结合及作用的影响。我们发现连接跨膜螺旋III(TMIII)和ECL-2的七跨膜(TM)受体保守二硫键(7TM桥)对于趋化因子和小分子作用至关重要,而N端与TMVII之间的趋化因子受体保守二硫键仅对趋化因子是必需的。此外,我们发现ECL-2中两个不同的芳香族残基,Tyr(184)(Cys + 1)和Tyr(187)(Cys + 4),分别对于CC趋化因子CCL1(激动剂)和MC148(拮抗剂)的结合至关重要,但对小分子结合并不重要。最后,通过计算机模拟,我们预测了TMIV(Phe(171))和TMV(Trp(194))中与Tyr(187)相互作用的芳香族残基簇。我们在体外表明这些残基对于MC148的结合和作用至关重要,从而支持它们与Tyr(187)参与形成芳香族残基簇。这种芳香族残基簇似乎存在于大量的CC趋化因子受体中,因此在未来针对这些受体的药物开发中可能发挥更普遍的作用。